Today, notable stocks experiencing activity include SPARC, Omaxe, Mastek, JSW Energy, Jindal (India), ITC, and Lyka Labs. Additionally, Airfloa Rail and Transformers & Rectifiers are also attracting attention among investors.

Omaxe secures a ₹75 crore investment for developing projects in Tier II cities, while Mastek appoints Amit Gajwani as COO for an orderly leadership transition. A SPARC partner encounters a Complete Response Letter (CRL) from the US FDA, JSW Energy increases its share in the Toshiba joint venture, and ITC strengthens its stake in Mother Sparsh to 49.3%.

Over the past five quarters, mutual funds have increased their investment in companies such as Apar Industries, Mastek, and BHEL, indicating a positive outlook due to solid fundamentals and promising long-term prospects across various industries.

Wipro and Kongsberg join forces for AI solutions in the energy sector, while Mastek announces a building sale worth INR 60 crore. Paytm clarifies RBI's decision to cancel their PPBL license, NLC India secures a mining license in Chhattisgarh, and Ampvolts partners with Cholamandalam for EV hub development.

Tech company Mastek has agreed to sell a 157,233 sq ft building in Chennai SEZ to Caresoft Mobility for approximately INR 60 crores. The sale will be completed in two tranches upon receiving necessary approvals.

Mastek Ltd has agreed to sell its commercial building in Mahindra World City, spanning approximately 1.57 lakh sq ft across 15.5 acres, to Caresoft Mobility for a sum of ₹60 crore.

Mutual fund investments have grown significantly in companies like Aavas Financiers, Mastek, Wakefit, and CE Info Systems during March 2026. These companies are witnessing growth in revenue, profitability, and expansion plans across various sectors and locations, suggesting a positive outlook for their future performance.

Mastek projects a stronger growth trajectory for FY27 despite challenges from AI pricing and broader economic uncertainties. The company's order book from the US has seen an increase sequentially, with analysts valuing it at ₹2,240 - representing a potential rise of 28%.

HDFC Securities maintains its positive outlook for Mastek, recommending a buy with a projected price of INR 2,250. Investors may consider this tech company a promising pick in the current market.

Mastek anticipates strong growth in the upcoming fiscal year (FY27), surpassing the previous year (FY26). However, management has not disclosed specific numerical projections for growth.

Mastek anticipates a robust expansion in North America for the fiscal year 2027, based on encouraging early signs. However, growth in AMEA might depend on resolving geopolitical issues, as suggested by company leadership.

Mastek aims for a balance of revenue growth and controlled headcount expansion, with a focus on improving revenue productivity by enhancing the efficiency of each team member. The company anticipates a rise in revenue per employee according to their projections.

Mastek anticipates executing its current 12-month order book, which could bolster the financial year 2027 (FY27) outlook by providing a stronger base than what was seen in FY26.

Mastek anticipates a consistent EBITDA margin of 16-16.5% by the financial year 2027, signaling a stable profitability forecast for the company. The earnings call confirms this optimistic outlook for Mastek's future profits.

Mastek has announced a wage increase for Q4, which could potentially lower their profit margins by 1-1.5%. This potential decrease in profitability was highlighted during the recent company update call.

Mastek Limited experiences a 7% boost in revenue for its FY26, accompanied by a 24.4% surge in backlog, which the company attributes to an increased momentum in Artificial Intelligence-related deals.

Mastek adjusts its projected EBITDA margin to 16.5%, a decrease from the initial 17%, due to intensifying competition in the industry. This move reflects the company's anticipation of increased challenges ahead.

Mastek, due to increased competition and a 1-1.5% wage increase in Q4, has adjusted its EBITDA margin outlook for the year, setting it at 16.5%. Despite this adjustment, they anticipate maintaining the same margin level for FY27.

Mastek shares soared by nearly 10% on strong Q4 earnings, surpassing the Sensex's growth. The impressive profit rise and positive market sentiment, even amid revenue concerns, fueled the increase in share price.

Mastek's Q4 EBIT dropped slightly to ₹1.33 billion, with a corresponding decrease in margins to 14.1% from 14.8%. This indicates a slight profit contraction compared to the previous quarter.

Mastek has announced that it will distribute a cash dividend of INR 16 per share to its shareholders. This move signals the company's strong financial performance and potential for continued growth.

Mastek has announced a dividend payout of ₹24 per share for the fiscal year 2025-26. This decision was made following the approval of their financial results and an unmodified opinion from auditors. The dividend comprises a final distribution of ₹16 per share.

Mastek's Q4 net profit declined by 2%, reaching ₹106.2 crores, with revenue rising by 3.6% to ₹938 crores. EBITDA also dropped by 2% to ₹215 crores, causing a decrease in margin to 22.9%. The company has proposed a final dividend of ₹16 per share for this quarter.

Mastek will reveal their Q4 and FY26 results on the 17th of April, 2026. For further insights, join the earnings call scheduled for the 20th of April, 10 AM IST. Details can be found on Mastek's website.

Mastek Ltd has allocated 6 lakh Employee Stock Options (ESOPs) as part of plans VI and VII, with a price of Rs. 1000 each. These options will vest over a period of 3-5 years, remaining exercisable for another 7 years.